Shopping Cart
- Remove All
Your shopping cart is currently empty
Imlunestrant (LY-3484356) is an orally active, selective estrogen receptor degrader that persistently inhibits ER-dependent gene transcription and cell growth. It is suitable for investigating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $66 | In Stock | |
| 5 mg | $158 | In Stock | |
| 10 mg | $248 | In Stock | |
| 25 mg | $397 | In Stock | |
| 50 mg | $569 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $185 | In Stock |
| Description | Imlunestrant (LY-3484356) is an orally active, selective estrogen receptor degrader that persistently inhibits ER-dependent gene transcription and cell growth. It is suitable for investigating ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. |
| In vitro | Imlunestrant exhibits favorable pharmacokinetic (PK) properties, including antitumor activity in ESR1 mutants [1]. |
| Synonyms | LY-3484356, LY3484356 |
| Molecular Weight | 524.51 |
| Formula | C29H24F4N2O3 |
| Cas No. | 2408840-26-4 |
| Color | Orange |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 140 mg/mL (266.92 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.